ProBioGen AG, a premier service and technology provider for complex therapeutic glycoproteins, and Pionyr Immunotherapeutics, an immuno-oncology company which develops next generation antibody-based therapeutics that target the tumor…
RaySearch, a medical technology company for innovative software solutions, and Eckert & Ziegler BEBIG have signed a partnership agreement. Both the RayStation® treatment planning system and the RayCare oncology information system will be integrated…
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that it has issued another tranche of the ODIRNANE bonds (undated bonds…
With a new blood test, researchers at the Charité – Universitätsmedizin Berlin can determine the state of the internal clock of a person. Once the internal rhythm of patient is known, drugs could be administered at particular times of day making them…
The European Commission (EC) announced that the FET Flagship RESTORE, which was initiated by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), has been selected to enter the next phase of the FET Flagship competition. A successful FET…
The validation fund of Berlin Health Innovations in cooperation with SPARK Berlin is entering its first round. 18 selected teams from the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz…
Proprietary Duck Cell Line Serves as Large-Scale Production-Suitable Cell Substrate
This year, Bayer G4A programs are embarking on one mission: to put people at the center of their health.
The 2018 Dealmaker program aims to connect mature startups and companies with a market-ready product or a solution in healthcare to tackle…
Joint press release by Berlin Institute of Health and Charité – Universtätsmedizin Berlin
Avoidable errors in preclinical research often result in patients being subjected to studies where the risks are high and the chances of success are low.…
Eckert & Ziegler AG, a specialist for scientific, medical, and industrial applications of radioisotopes, has been selected as manufacturing partner for clinical supply of Bayer's innovative Targeted Thorium Conjugates (TTCs) in Europe. TTCs are a…
